EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+48.42%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$1.05B
AUM Growth
+$1.05B
(+41%)
Cap. Flow
+$108M
Cap. Flow
% of AUM
10.23%
Top 10 Holdings %
Top 10 Hldgs %
64.97%
Holding
54
New
17
Increased
9
Reduced
10
Closed
10
Top Buys
| 1 |
Arvinas
ARVN
|
$55M |
| 2 |
Assembly Biosciences
ASMB
|
$46.9M |
| 3 |
AnaptysBio
ANAB
|
$31.9M |
| 4 |
IPHA
Innate Pharma
IPHA
|
$29.3M |
| 5 |
Merus
MRUS
|
$21.9M |
Top Sells
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$69.3M |
| 2 |
argenx
ARGX
|
$52.8M |
| 3 |
Solid Biosciences
SLDB
|
$34.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
$14.3M |
| 5 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$9.1M |
Sector Composition
| 1 | Healthcare | 92.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Solid Biosciences
SLDB
$427M
| – | – |
-3,342,691
| Closed | -$34.6M |
|
|
52
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
-189,745
| Closed | -$14.3M |
|
|
UBX
53
DELISTED
Unity Biotechnology
UBX
| – | – |
-51,400
| Closed | -$314K |
|
|
ONCE
54
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| – | – |
-714,789
| Closed | -$69.3M |
|